|
| 36727595 | Benefits, harms, and costs of newborn genetic screening for hypertrophic cardiomyopathy: Estimates from the PreEMPT model. | Genet Med | 2023 |
| 37458095 | Attitudes about pharmacogenomic testing vary by healthcare specialty. | Pharmacogenomics | 2023 |
| 37279760 | Actionability of unanticipated monogenic disease risks in newborn genomic screening: Findings from the BabySeq Project. | Am J Hum Genet | 2023 |
| 37102213 | Public perspective on medications to delay Alzheimer's disease symptoms. | J Genet Couns | 2023 |
| 37232094 | <i>SLCO1B1</i> gene-based clinical decision support reduces statin-associated muscle symptoms risk with simvastatin. | Pharmacogenomics | 2023 |
| 34309124 | Effects of participation in a U.S. trial of newborn genomic sequencing on parents at risk for depression. | J Genet Couns | 2022 |
| 35775396 | Progression of precision statin prescribing for reduction of statin-associated muscle symptoms. | Pharmacogenomics | 2022 |
| 35571041 | Parental Attitudes Toward Standard Newborn Screening and Newborn Genomic Sequencing: Findings From the BabySeq Study. | Front Genet | 2022 |
| 35446370 | Association of Pathogenic Variants in Hereditary Cancer Genes With Multiple Diseases. | JAMA Oncol | 2022 |
| 36422106 | Workforce Considerations When Building a Precision Medicine Program. | J Pers Med | 2022 |
| 36483158 | Awareness and utilization of genetic testing among Hispanic and Latino adults living in the US: The Hispanic Community Health Study/Study of Latinos. | HGG Adv | 2022 |
| 35216901 | The reckoning: The return of genomic results to 1444 participants across the eMERGE3 Network. | Genet Med | 2022 |
| 34906462 | Improved provider preparedness through an 8-part genetics and genomic education program. | Genet Med | 2022 |
| 34665896 | Do research participants share genomic screening results with family members? | J Genet Couns | 2022 |
| 34113000 | Primary care providers' responses to unsolicited Lynch syndrome secondary findings of varying clinical significance. | Genet Med | 2021 |
| 33767345 | Universal newborn genetic screening for pediatric cancer predisposition syndromes: model-based insights. | Genet Med | 2021 |
| 34429410 | Behavioral and psychological impact of genome sequencing: a pilot randomized trial of primary care and cardiology patients. | NPJ Genom Med | 2021 |
| 34752750 | Returning actionable genomic results in a research biobank: Analytic validity, clinical implementation, and resource utilization. | Am J Hum Genet | 2021 |
| 34661666 | Estimated Cost-effectiveness of Genetic Testing in Siblings of Newborns With Cancer Susceptibility Gene Variants. | JAMA Netw Open | 2021 |
| 34424265 | Psychosocial Effect of Newborn Genomic Sequencing on Families in the BabySeq Project: A Randomized Clinical Trial. | JAMA Pediatr | 2021 |
| 34834475 | A Cost-Consequence Analysis of Preemptive <i>SLCO1B1</i> Testing for Statin Myopathy Risk Compared to Usual Care. | J Pers Med | 2021 |
| 32349224 | Returning Results in the Genomic Era: Initial Experiences of the eMERGE Network. | J Pers Med | 2020 |
| 32389220 | Quantifying Downstream Healthcare Utilization in Studies of Genomic Testing. | Value Health | 2020 |
| 32211507 | Disclosing genetic risk for Alzheimer's dementia to individuals with mild cognitive impairment. | Alzheimers Dement (N Y) | 2020 |
| 30670880 | Correction: Secondary findings from clinical genomic sequencing: prevalence, patient perspectives, family history assessment, and health-care costs from a multisite study. | Genet Med | 2019 |
| 30919684 | Phenotypic Characterization of Individuals With Variants in Cardiovascular Genes in the Absence of a Primary Cardiovascular Indication for Testing. | Circ Genom Precis Med | 2019 |
| 30287922 | Secondary findings from clinical genomic sequencing: prevalence, patient perspectives, family history assessment, and health-care costs from a multisite study. | Genet Med | 2019 |
| 28726810 | A randomized controlled trial of disclosing genetic risk information for Alzheimer disease via telephone. | Genet Med | 2018 |
| 29986673 | The BabySeq project: implementing genomic sequencing in newborns. | BMC Pediatr | 2018 |
| 30224109 | Cost Analyses of Genomic Sequencing: Lessons Learned from the MedSeq Project. | Value Health | 2018 |
| 30224106 | Methodological Issues in Assessing the Economic Value of Next-Generation Sequencing Tests: Many Challenges and Not Enough Solutions. | Value Health | 2018 |
| 30325721 | Communication Predictors of Patient and Companion Satisfaction with Alzheimer's Genetic Risk Disclosure. | J Health Commun | 2018 |
| 29388940 | Anticipated responses of early adopter genetic specialists and nongenetic specialists to unsolicited genomic secondary findings. | Genet Med | 2018 |
| 29471711 | Enhancing Autonomy in Biobank Decisions: Too Much of a Good Thing? | J Empir Res Hum Res Ethics | 2018 |
| 29565423 | Short-term costs of integrating whole-genome sequencing into primary care and cardiology settings: a pilot randomized trial. | Genet Med | 2018 |
| 29203084 | The impact of genetic counselors' use of facilitative strategies on cognitive and emotional processing of genetic risk disclosure for Alzheimer's disease. | Patient Educ Couns | 2018 |
| 29300387 | Patient understanding of, satisfaction with, and perceived utility of whole-genome sequencing: findings from the MedSeq Project. | Genet Med | 2018 |
| 28012682 | Disclosing genetic risk of Alzheimer's disease to cognitively impaired patients and visit companions: Findings from the REVEAL Study. | Patient Educ Couns | 2017 |
| 28421887 | Preferences for the Return of Individual Results From Research on Pediatric Biobank Samples. | J Empir Res Hum Res Ethics | 2017 |
| 28949844 | When bins blur: Patient perspectives on categories of results from clinical whole genome sequencing. | AJOB Empir Bioeth | 2017 |
| 28654958 | The Impact of Whole-Genome Sequencing on the Primary Care and Outcomes of Healthy Adult Patients: A Pilot Randomized Trial. | Ann Intern Med | 2017 |
| 25708169 | Disclosing genetic risk for coronary heart disease: effects on perceived personal control and genetic counseling satisfaction. | Clin Genet | 2016 |
| 27148937 | Family health history reporting is sensitive to small changes in wording. | Genet Med | 2016 |
| 27019659 | Patients' perceived utility of whole-genome sequencing for their healthcare: findings from the MedSeq project. | Per Med | 2016 |
| 26928896 | Participants and Study Decliners' Perspectives About the Risks of Participating in a Clinical Trial of Whole Genome Sequencing. | J Empir Res Hum Res Ethics | 2016 |
| 26820063 | Adopting genetics: motivations and outcomes of personal genomic testing in adult adoptees. | Genet Med | 2016 |
| 26810768 | Disclosing Pleiotropic Effects During Genetic Risk Assessment for Alzheimer Disease: A Randomized Trial. | Ann Intern Med | 2016 |
| 26080898 | Are physicians prepared for whole genome sequencing? a qualitative analysis. | Clin Genet | 2016 |
| 25539761 | Erratum to: How can psychological science inform research about genetic counseling for clinical genomic sequencing? | J Genet Couns | 2015 |
| 26376753 | Participant Satisfaction With a Preference-Setting Tool for the Return of Individual Research Results in Pediatric Genomic Research. | J Empir Res Hum Res Ethics | 2015 |